Home
About
Overview
Sharing Data
ORCID
Help
History (1)
[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].
[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases]. An Sist Sanit Navar. 2006 Jan-Apr; 29(1):77-96.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antigens, CD
Antigens, Differentiation
Antineoplastic Agents
Autoimmunity
Bone Marrow Transplantation
Cancer Vaccines
Chronic Disease
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
CTLA-4 Antigen
Cytokines
Humans
Immunotherapy
Mice
Mice, Transgenic
Neoplasms
Neoplasms, Experimental
Receptors, Nerve Growth Factor
Receptors, Tumor Necrosis Factor
Transplantation, Homologous
Tumor Cells, Cultured
Tumor Necrosis Factor Receptor Superfamily, Member 9
Viral Vaccines
Virus Diseases
authors with profiles
Ainhoa Arina